Differential expression of anti-angiogenic factors and guidance genes in the developing macula

Molecular Vision

Volumn 15, Issue , 2009, Pages 45-59

  Kozulin, Peter ^a   Natoli, Riccardo ^a   Bumsted O'Brien, Keely M ^a   Madigan, Michele C ^b,c   Provis, Jan M ^a,d  

^a AUSTRALIAN NATIONAL UNIVERSITY   (Australia)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

^c UNIVERSITY OF SYDNEY   (Australia)

^d The Australian National University   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN TYPE 4; EPHRIN; MESSENGER RNA; NATRIURETIC FACTOR; PIGMENT EPITHELIUM DERIVED FACTOR; RNA; SEMAPHORIN;

ANGIOGENESIS; ANIMAL TISSUE; ARTICLE; COLOR VISION; CONTROLLED STUDY; FETUS; GAS CHROMATOGRAPHY; GENE CLUSTER; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE IDENTIFICATION; GENE LOCATION; GENETIC REGULATION; GESTATION PERIOD; HUMAN; HUMAN TISSUE; HYBRIDIZATION; IN SITU HYBRIDIZATION; MACACA; NERVE FIBER; NEURAL STEM CELL; NONHUMAN; NUCLEOTIDE SEQUENCE; PHOTORECEPTOR; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; QUALITY CONTROL; RETINA BLOOD VESSEL; RETINA DEVELOPMENT; RETINA FOVEA; RETINA GANGLION CELL; RETINA MACULA LUTEA; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UPREGULATION; VISUAL ACUITY;

ADULT; ANGIOGENESIS INHIBITORS; ANIMALS; AXONS; EYE PROTEINS; FETUS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, DEVELOPMENTAL; HUMANS; IN SITU HYBRIDIZATION; MACACA; MACULA LUTEA; MEMBRANE PROTEINS; MULTIGENE FAMILY; NERVE GROWTH FACTORS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; QUALITY CONTROL; RNA, MESSENGER; SERPINS;

EID: 58449087606     PISSN: None     EISSN: 10900535     Source Type: Journal    
DOI: None     Document Type: Article

References (73)

1. Provis JM, Penfold PL, Cornish EE, Sandercoe TM, Madigan MC. Anatomy and development of the macula: specialisation and the vulnerability to macular degeneration. Clin Exp Optom 2005; 88:269-81.
2. Penfold PL, Madigan MC, Gillies MC, Provis JM. Immunological and aetiological aspects of macular degeneration. Prog Retin Eye Res 2001; 20:385-414.
3. Hageman GS, Anderson DH, Johnson LV, Hancox LS, Taiber AJ, Hardisty LI, Hageman JL, Stockman HA, Borchardt JD, Gehrs KM, Smith RJ, Silvestri G, Russell SR, Klaver CC, Barbazetto I, Chang S, Yannuzzi LA, Barile GR, Merriam JC, Smith RT, Olsh AK. Bergeron J, Zernant J, Merriam JE, Gold B, Dean M, Allikmets R. A common haplotype in the complement regulatory gene factor H (HFI/CFH) predisposes individuals to age-related macular degeneration. Proc Natl Acad Sci USA 2005, 102:7227-32.
4. Haines JL. Hauser MA, Schmidt S, Scott WK. Olson LM. Gallins P, Spencer KL, Kwan SY, Noureddine M. Gilbert JR, Schnetz-Boutaud N. Agarwal A, Postel EA. Pericak-Vance MA. Complement factor H variant increases the risk of age-related macular degeneration. Science 2005; 308:419-21.
5. Klein RJ, Zeiss C, Chew EY, Tsai JY, Sackler RS. Haynes C, Henning AK, SanGiovanni JP. Mane SM, Mayne ST. Bracken MB, Ferris FL. Ott J, Barnstable C, Hoh J. Complement factor H polymorphism in age-related macular degeneration. Science 2005, 308:385-9.
6. Yang Z, Stratton C, Francis PJ, Kleinman ME. Tan PL. Gibbs D, Tong Z. Chen H. Constantine R, Yang X, Chen Y. Zeng J. Davey L, Ma X. Hau VS, Wang C, Harmon J. Buehler J, Pearson E, Patel S. Kaminoh Y, Watkins S, Luo L. Zabriskie NA, Bernstein PS, Cho W. Schwager A. Hinton DR. Klein ML, Hamon SC, Simmons E, Yu B, Campochiaro B, Sunness JS, Campochiaro P, Jorde L, Parmigiani G, Zack DJ, Katsanis N, Ambati J, Zhang K. Toll-like receptor 3 and geographic atrophy in age-related macular degeneration. N Engl J Med 2008; 359:1456-63.
7. Bernstein SL, Borst DE, Wong PW. Isolation of differentially expressed human fovea genes: candidates for macular disease. Mol Vis 1995; 1:4.
8. Bernstein SL, Borst DE, Neuder ME, Wong P. Characterization of a human fovea cDNA library and regional differential gene expression in the human retina. Genomics 1996,: 32:301-8.
9. Sharon D, Blackshaw S, Cepko CL, Dryja TP. Profile of the genes expressed in the human peripheral retina. rnacula. and retinal pigment epithelium determined through serial analysis of gene expression (SAGE). Proc Natl Acad Sci USA 2002: 99:315-20.
10. Bowes Rickman C, Ebright IN, Zavodni ZJ, Yu L, Wang T, Daiger SP, Wistow G, Boon K, Hauser MA. Defining the human macula transcriptome and candidate retinal disease genes using EyeSAGE. Invest Ophthalmol Vis Sci 2006; 47:2305-16.
11. Franco EC, Finlay BL, Silveira LC, Yamada ES, Crowley JC. Conservation of absolute foveal area in New World monkeys. A constraint on eye size and conformation. Brain Behav Evol 2000; 56:276-86.
12. Engerman RL. Development of the macular circulation. Invest Ophthalmol 1976; 15:835-40.
13. Provis JM, Hendrickson A.E. The foveal avascular region of developing human retina. Arch Ophthalmol 2008; 126:507-11.
14. McGuire DE, Weinreb RN, Goldbaum MH. Foveal hypoplasia demonstrated in vivo with optical coherence tomography. Am J Ophthalmol 2003; 135:112-4.
15. Marmor MF, Choi SS, Zawadzki RJ, Werner JS. Visual insignificance of the foveal pit: reassessment of foveal hypoplasia as fovea plana. Arch Ophthalmol 2008; 126:907-13.
16. Sandercoe TM, Geller SF, Hendrickson AE, Stone J, Provis JM. VEGF expression by ganglion cells in central retina, before formation of the foveal depression in monkey retina-evidence of developmental hypoxia. J Comp Neurol 2003; 462:42-54.
17. Stone J, Sandercoe TM, Provis JM. Mechanisms of the formation and stability of retinal blood vessels. In: Tombran-Tink J. Barnstable C, editors. Ocular Angiogenesis: Diseases, Mechanisms and Therapeutics. Totowa, NJ: Humana Press; 2005. p. 101-26.
18. Provis JM, Sandercoe T, Hendrickson AE. Astrocytes and blood vessels define tile foveal rim during primate retinal development. Invest Ophthalmol Vis-Sci 2000. 41:2827-36.
19. Provis JM. Development of the primate retinal vasculature. Prog Retin Eye Res 2001, 20:799-821.
20. Hendrickson A, Troilo D, Possin D, Springer A. Development of the neural retina and its vasculature in tile marmoset Callithrixjacchus. J Comp Neurol 2006.497:270-86. :
21. Ohno-Matsui K, Morita I. Tombran-Tink J, Mrazek D, Onodera M, Uetama T, Havano M, Murota SI, Mochizuki M. Novel mechanism for age-related macular degeneration: an equilibrium shift between the angiogenesis factors VEGF and PEDF. J Cell Physiol 2001; 189:323-33.
22. Park KW, Crouse D, Lee M, Karnik SK, Sorensen LK, Murphy KJ, Kuo CJ, Li DY. The axonal attractant Netrin-I is an angiogenic factor. Proc Natl Acad Sci USA 20K 101:16210-5.
23. Schroeder A, Mueller O, Stocker S, Salowsky R, Leiber M, Gassmann M, Lightfoot S. Menzel W, Granzow M. Ragg T. The RIN: an RNA integrity number for assigning integrity values to RNA measurements. BMC Mol Biol 2006. 7:3.
24. O'Brien KM, Schulte D, Hendrickson AE. Expression of photoreceptor-associated molecules during human fetal eye development. Mol Vis 2003: 9:401-9.
25. Wu Z. Irizarry RA, A statistical framework for the analysis of microarray probe-level data. John Hopkins University Dept. of Biostatistics Working Papers, Working Paper 73. The Berkeley Electronic Press: 2005.
26. Bolstad BM, Irizarry RA, Astrand M, Speed TP. A comparison of normalization methods for high density oligonucleotide array data based on variance and bias. Bioinformatics 2003; 19:185-93.
27. Irizarry RA, Hobbs B, Collin F, Beazer-Barclay YD, Antonellis KJ, Scherf U, Speed TP. Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatisties 2003; 4:249-64,
28. The Gene Ontology Consortium. Gene Ontology: tool for the unification of biology. Nat Genet 2000; 25:25-9.
29. Dennis G Jr, Sherman BT, Hosack DA, Yang J, Gao W, Lane HC, Lempicki RA. DAVID: Database for Annotation, Visualization, and Integrated Discovery. Genome Biol 2003; 4:P3.
30. Provis JM, van Driel D, Billson FA, Russell P. Development of the human retina: patterns of cell distribution and redistribution in the ganglion cell layer. J Comp Neurol 1985; 233:429-51.
31. Pfaffl MW. A new mathematical model for relative qualltification in real-time RT-PCR. Nucleic Acids Res 2001; 29:e45.
32. Cornish EE, Madigan MC, Natoli R, Hales A, Hendrickson AE, Provis JM. Gradients of cone differentiation and FGF expression during development of the foveal depression in macaque retina. Vis Neurosci 2005. 22:447-59.
33. Rollin R, Mediero A, Roldan-Pallares M, Fernandez-Craz A, Fernandez-Durango R. Natriuretic peptide system in the human retina. Mol Vis 2004, 10:15-22.
34. Tombran-Tink J, Shivaram SM, Chader GJ, Johnson LV, Bok D. Expression, secretion. and age-related downregulation of pigment epithelium-derived factor. a serpin with neurotrophic activity. J Neurosci 1995: 15:4992-5003.
35. Provis J, Kozulin P. Gene expression in central vs peripheral primate retina - defining the foveal avascular zone. J Vis 2007: 7:31a.
36. Karakousis PC, John SK, Behling KC, Surace EM, Smith JE, Hendrickson A, Tang WX, Bennett J, Milam AH. Localization of pigment epithelium derived factor (PEDF) in developing and adult human ocular tissues. Mol Vis 2001; 7:154-63.
37. van Soest SS, de Wit GM, Essing AH, ten Brink JB, Kamphuis W. de Jong PT, Bergen AA. Comparison of human retinal pigment epithelium gene expression in macula and periphery highlights potential topographic differences in Bruch's membrane. Mol Vis 2007; 13:1608-17.
38. Li HM. Wang F, Qiu W, Liu Y. Huang Q. Expression patterns of the retinal development-related genes in the fetal and adult retina. Chin Med J (Engl) 2007: 120:1716-9.
39. Tombran-Tink J, Barnstable CJ. PEDF: a multifaceted neurotrophic factor. Nat Rev Neurosci 2003. 4:628-36.
40. Dawson DW, Volpert OV, Gillis P, Crawford SE, Xu H, Benedict W, Bolick NP. Pigment epithelium-derived factor: a potent inhibitor of angiogenesis. Science 1999, 285:245-8.
41. Huang Q, Wang S, Sorenson CM, Sheibani N. PEDF-deficient mice exhibit all enhanced rate of retinal vascular expansion and are more sensitive to hyperoxia-mediated vessel obliteration. Exp Eye Res 2008; 87:226-41.
42. Volpert OV, Zaichuk T, Zhou W, Reiher F, Ferguson TA, Stuart PM, Amin M, Bouck NP. Inducer-stimulated Fas targets activated endothelium for destruction by anti-angiogenic thrombospondin-1 and pigment epithelium-derived factor. Nat Med 2002; 8:349-57.
43. Cai J, Jiang WG, Grant MB, Boulton M. Pigment epithelium-derived factor inhibits angiogenesis via regulated intracellular proteolysis of vascular endothelial growth factor receptor 1. J Biol Chem 2006; 281:3604-13.
44. Levin ER, Gardner DG, Samson WK. Natriuretic peptides. N Engl J Med 1998; 339:321-8.
45. Cao LH, Yu YC, Zhao JW, Yang XL. Expression of natriuretic peptides in rat Muller cells. Neurosci Lett 2004; 365:176-9.
46. Jin Y, Zhong YM, Yang XL. Natriuretic peptides are localized to rat retinal amacrine cells. Neurosci Lett 2007; 421:106-9.
47. Chinkers M, Garbers DL, Chang MS, Lowe DG, Chin HM, Goeddel DV, Schulz S. A membrane form of guanylate cyclase is an atrial natriuretic peptide receptor. Nature 1989; 338:78-83.
48. Pedram A, Razandi M, Hu RM, Levin ER. Vasoactive peptides modulate vascular endothelial cell growth factor production and endothelial cell proliferation and invasion. J Biol Chem 1997; 272:17097-103.
49. Pedram A, Razandi M, Levin ER. Natriuretic peptides suppress vascular endothelial cell growth factor signaling to angiogenesis. Endocrinology 2001; 142:1578-86.
50. Maragoudakis ME, Missirlis E, Karakiulakis GD, Sarmonica M, Bastakis M, Tsopanoglou N. Basement membrane biosynthesis as a target for developing inhibitors of angiogenesis with anti-tumor properties. Kidney Int 1993: 43:147-50.
51. Mundel TM, Kalluri R. Type IV collagen-derived angiogenesis inhibitors. Microvasc Res 2007; 74:85-9.
52. Suchting S, Bicknell R, Eichmann A. Neuronal clues to vascular guidance. Exp Cell Res 2006, 312:668-75.
53. La Vail MM, Rapaport DH, Rakic P. Cytogenesis in the monkey retina. J Comp Neurol 1991; 309:86-114.
54. Rapaport DH, Stone J. The topography of cytogenesis in the developing retina of the cat. J Neurosci 1983; 3:1824-34.
55. Mann IC. The development of the human eye. New York: Grune and Stratton: 1964.
56. Hendrickson A, Provis IM. Comparison of development of the primate fovea centralis with peripheral retina. In: Sernagor E, Eglen S, Harris B, Wong R, editors. Retinal Development. Cambridge: Cambridge University Press, 2006. p. 126-49.
57. Provis JM, van Driel D, Billson FAB, Russell P. Human fetal optic nerve: overproduction and elimination of retinal axons during development. J Comp Neurol 1985; 238:92-100.
58. Lumbot MA, Depasse F, Noel JC, Vanderhaeghen P. Mapping labels in the human developing visual system and the evolution of binocular vision. J Neurosci 2005; 25:7232-7.
59. Birgbauer E, Cowan CA, Sretavan DW, Henkemeyer M. Kinase independent function of EphB receptors in retinal axon pathfinding to the optic disc from dorsal but not ventral retina. Development 2000; 127:1231-41.
60. Oster SF, Deiner M, Birgbauer E, Sretavan DW. Ganglion cell axon pathfinding in the retina and optic nerve. Semin Cell Dev Biol 2004; 15:125-36.
61. Brown A, Yates PA, Burrola P, Ortuño D, Vaidya A, Jessell TM, Pfaff SL, O'Leary DD, Lemke G. Topographic mapping from the retina to the midbrain is controlled by relative but not absolute levels of EphA receptor signaling. Cell 2000; 102:77-88.
62. Knöll B, Drescher U. Ephrin-As as receptors in topographic projections. Trends Neurosci 2002; 25:145-9.
63. McLaughlin T, Hindges R, O'Leary DD. Regulation of axial patterning of the retina and its topographic mapping in the brain. Curr Opin Neurobiol 2003; 13:57-69.
64. Huberman AD, Murray KD, Warland DK, Feldheim DA, Chapman B. Ephrin-As mediate targeting of eye-specific projections to the lateral geniculate nucleus. Nat Neurosci 2005; 8:1013-21.
65. Pfeiffenberger C, Cutforth T, Woods G, Yamada J, Rentería RC, Copenhagen DR, Flanagan JG, Feldheim DA. Ephrin-As and neural activity are required for eye-specific patterning during retinogeniculate mapping. Nat Neurosci 2005; 8:1022-7.
66. Serini G, Valdembri D, Zanivan S, Morterra G, Burkhardt C, Caccavari F, Zammataro L, Primo L, Tamagnone L, Logan M, Tessier-Lavigne M, Taniguchi M, Püschel AW, Bussolino F. Class 3 semaphorins control vascular morphogenesis by inhibiting integrin function. Nature 2003; 424:391-7.
67. Pfaff D, Fiedler U, Augustin HG. Emerging roles of the Angiopoietin-Tie and the ephrin-Eph systems as regulators of cell trafficking. J Leukoc Biol 2006; 80:719-26.
68. Lu X, Le Noble F, Yuan L, Jiang Q, De Lafarge B. Sugiyama D, Bréant C, Claes F, De Smet F, Thomas JL, Autiero M, Carmeliet P, Tessier-Lavigne M, Eichmann A. The netrin receptor UNC5B mediates guidance events controlling morphogenesis of the vascular system. Nature 2004; 432:179-86.
69. Cowan CA, Henkemeyer M. Ephrins in reverse, park and drive. Trends Cell Biol 2002; 12:339-46.
70. Curcio CA, Sloan KR, Kalina RE, Hendrickson AE. Human photoreceptor topography. J Comp Neurol 1990: 292:497-523.
71. Putnam NM, Hofer HJ, Doble N, Chen L, Carroll J, Williams DR. The locus of fixation and the foveal cone mosaic, J Vis 2005; 5:632-9.
72. Adams DL, Horton JC. Shadows cast by retinal blood vessels mapped in primary visual cortex. Science 2002; 298:572-6.
73. Springer AD, Hendrickson AE. Development of the primate area of high acuity. 3: temporal relationships between pit formation, retinal elongation and cone packing. Vis Neurosci 2005; 22:171-85.